Sunday, November 08, 01:22 pm IST
Hot Searches:  Reliance, Interest Rates, Corporate Earnings
| Feedback
LATEST NEWS
In Markets
10 companies that MF managers love
Do you own these picks? read more
In Technology
Rough road to riches
Chinese Internet start-ups get crimped on crowded Web read more
In Trends
Technology enhances social world
A US study finds that technology is not isolating people, as is perceived. read more
twitter
Aurobindo gets approval for Sumatriptan Succinate tabs
Published on Fri, Feb 01, 2008 at 14:13  |  Updated at Fri, Feb 01, 2008 at 14:26  |  Source : Moneycontrol.com
Email
Print
Blish This

Aurobindo Pharma Limited is pleased to announce that the company has received tentative approval from the US Food & Drug Administration to manufacture and market Sumatriptan Succinate Tablets 25mg, 50mg and 100mg.

 


Sumatriptan Succinate Tablets are the generic equivalent of GlaxoSmithKline's Imitrex® Tablets, which are indicated for the treatment of acute migraine headaches.

 

Annual sales of Sumatriptan Succinate Tablets 25mg, 50mg and 100m. in the US were approximately US$ 950 million for the twelve months ending MAT/3/2007 according to IMS Health data

 

This is Aurobindo’s 63rd ANDA approval from the USFDA 

 

Sourced From: Aurobindo Pharma Limited

Important Links Today:  Leadership Wall    Chat Calendar    The 10 List   
Tags: Aurobindo Pharma, Sumatriptan Succinate Tablets , GlaxoSmithKline, Imitrex® Tablets, migraine
WE ARE 10 !
Leadership Wall

Today's Special Column

with Kishore Biyani
Future Group and the MD of Pantaloon Retail (India) Limited , Group CEO

Next Gen entrepreneurs are the future of this country

Leadership Chat

Special Chat

with Sunil Singhania
Fund Manager , Reliance MF
09 Nov- 15:30hrs

Chat Calendar

WHAT OTHERS LIKE
  • Most Read
  • Most Viewed

NEWS FROM OUR NETWORK

Udayan Speak

New Venture

NEWS FROM OUR PARTNERS
©Network 18, 2009. All Rights Reserved